1. Perafan-Riveros C, Franca LF, Alves AC, Sanches JA Jr. Acrodermatitis enteropathica: case report and review of the literature. Pediatr Dermatol. 2002. 19:426–431.
2. Miller SJ. Nutritional deficiency and the skin. J Am Acad Dermatol. 1989. 21:1–30.
Article
3. Krasovec M, Frenk E. Acrodermatitis enteropathica secondary to Crohn's disease. Dermatology. 1996. 193:361–363.
Article
4. Kim BC, Joo KR, Lee HS, Jeong YK, Suh HS, Kim DH, Park NM, Park JH. A case of chronic pancreatitis associated with liver infarction and acrodermatitis enteropathica. Korean J Intern Med. 2002. 17:263–265.
Article
5. Sawai T, Sugiura H, Danno K, Uchiyama M, Ohta S. Acquired acrodermatitis enteropathica during chemotherapy for acute lymphocytic leukemia in a child with Down syndrome. Br J Dermatol. 1996. 135:659–660.
6. Jang MS, Kim YJ, Chae YS, Suh KS, Kim ST. A case of necrolytic migratory erythema induced by a pancreatic insufficiency. Korean J Dermatol. 1996. 34:166–170.
7. Park MA, Ha SG, Won YH, Chun IK. A case of protein energy malnutrition after Whipple's operation. Korean J Dermatol. 1994. 32:130–133.
8. Seo KH, Park JH, Jang HS, Kwon KS, Chung TA. A case of pseudoglucagonoma syndrome treated with medium-chain triglyceride. Korean J Dermatol. 1997. 35:593–599.
9. Krieger J, Evans GW. Acrodermatitis enteropathica without hypozincemia: therapeutic effect of a pancreatic enzyme preparation due to zinc binding ligand. J Pediatr. 1980. 96:32–35.
10. Neldner KN, Hambidge KM. Zinc therapy of acrodermatitis enteropathica. N Eng J Med. 1975. 292:879–882.
Article
11. Kang JD, You DO, Park SD. A case of transient acrodermatitis enteropathica. Korean J Dermatol. 2003. 41:786–789.
12. McLaren DS. Skin in protein energy malnutrition. Arch Dermatol. 1987. 123:1674–1676.
Article
13. Hansen RC, Lynch PJ, Morrow GM. Proteolytic deficiency causing acrodermatitis enteropathica. Clin Res. 1976. 24:168.
14. Golden MH, Golden BE, Jackson AA. Skin breakdown in kwashiorkor responds to zinc. Lancet. 1980. 1:1256.
Article
15. Schreiner V, Gooris GS, Pfeiffer S, Lanzendorfer G, Wenck H, Diembeck W, Proksch E, Bouwstra J. Barrier characteristics of different human skin types investigated with X-ray diffraction, lipid analysis, and electron microscopy imaging. J Invest Dermatol. 2000. 114:654–660.
Article
16. Lowe NJ, Stoughton RB. Essential fatty acid deficient hairless mouse: a model of chronic epidermal hyperproliferation. Br J Dermatol. 1977. 96:155–162.
Article
17. Ziboh VA, Cho Y, Mani I, Xi S. Biological significance of essential fatty acids/prostanoids/lipoxygenase-derived monohydroxy fatty acids in the skin. Arch Pharm Res. 2002. 25:747–758.
18. Ginsburg R, Robertson A Jr, Michel B. Acrodermatitis enteropathico: abnormalities of fat metabolism and integumental ultrastructures in infants. Arch Dermatol. 1976. 112:653–660.
Article
19. Horrobin DF, Cunnane SC. Interactions between zinc, essential fatty acids and prostaglandins: relevance to acrodermatitis enteropathica, total parenteral nutrition, the glucagonoma syndrome, diabetes, anorexia nervosa and sickle cell anemia. Med Hypotheses. 1980. 6:277–296.
20. Schroeter AL, Tucker SB, Minn R. Essential fatty acid deficiency. Arch Dermatol. 1978. 114:800–801.
Article
21. Schwartz RA. Glucagonoma and pseudoglucagonoma syndromes. Int J Dermatol. 1997. 36:81–89.
Article
22. Blackford S, Wright S, Robert DL. Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acids. Br J Dermatol. 1991. 125:460–462.
Article